Return to content in this issue
A 1-Bag/4-Step Rapid Desensitization Protocol to Reintroduce Agalsidase a in a Patient With Fabry Disease
Jimenez-Rodriguez TW1,2*, Soriano Gomis V1,2,3, Burgos San-José A4, Montoyo Antón RA5, González Delgado MP1,2,3, Gallego Velez CP1, Ortolano S6, Fernández J1,2,3, Sánchez Martínez R7
1Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
2ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII). Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain
3Department of Clinical Medicine, Miguel Hernández University, San Juan, Alicante, Spain
4Pharmacy Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
5Oncology Day Hospital Nursing Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
6Rare Diseases and Pediatric Medicine Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain
7Internal Medicine Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain
J Investig Allergol Clin Immunol 2025; Vol. 35(2)
doi: 10.18176/jiaci.1044
Key words: Agalsidase a, Agalsidase ß, Immunologic desensitization, Drug Hypersensitivity, Fabry Disease
Title | Type | Size | |
---|---|---|---|
doi10.18176_jiaci.1044_supplemental-materials-figure.pdf | 233.69 Kb |